Double Filtration Plasmapheresis for Refractory Hypercholesterolemia in Drug‐Induced Cholestasis: A Case Report
Journal of Clinical Apheresis · 2026-04 · 41 (2)
DOI: 10.1002/jca.70117 ↗At a glance
Fallbericht in Journal of Clinical Apheresis, published online on 2026-03-27. Written by Yuling Liang and 5 co-authors. Institution: Department of Nephrology, Center of Nephrology and Urology, the Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China. Major MEDLINE topics: Hypercholesterolemia, Plasmapheresis, Cholestasis. 15 references. Funded by: the Hospital Research Fund of SAHSYSU, the Seventh Affiliated Hospital, Sun Yat-sen University Clinical Research 735 Program, Sanming Project of Medicine in Shenzen Municipality.
Abstract (original language)
While lipoprotein apheresis (LA) is established for lipid management in primary biliary cholangitis, the role of apheresis techniques in drug‐induced cholestatic liver disease remains unexplored. We report the novel application of double filtration plasmapheresis (DFPP) for rapid reversal of severe hypercholesterolemia in iatrogenic cholestasis, where conventional therapies failed or were contraindicated. A 56‐year‐old male developed severe cholestatic hepatitis following the use of herbal agents. Laboratory investigation revealed extreme hypercholesterolemia, with a total cholesterol (TC) of 41.39 mmol/L and a low‐density lipoprotein cholesterol (LDL‐c) of 38 mmol/L. Standard medical therapy proved ineffective. Two sessions of DFPP resulted in > 90% reduction in cholesterol levels and simultaneous improvement in bilirubin and liver enzymes, with sustained normal levels at 1‐year follow‐up. DFPP may serve as a novel rescue therapy for drug‐induced cholestatic hypercholesterolemia, providing simultaneous removal of cholesterol and bilirubin where other treatments are ineffective or at high risk.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Nephrology, Center of Nephrology and Urology, the Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China.
Funding
- the Hospital Research Fund of SAHSYSU
- the Seventh Affiliated Hospital, Sun Yat-sen University Clinical Research 735 Program
- Sanming Project of Medicine in Shenzen Municipality
Cite
APA
Liang, Y., Zhu, W., Yang, D., Zheng, Z., Wang, X., & Lei, Y. (2026). Double Filtration Plasmapheresis for Refractory Hypercholesterolemia in Drug‐Induced Cholestasis: A Case Report. Journal of Clinical Apheresis, 41(2). https://doi.org/10.1002/jca.70117
Vancouver
Liang Y, Zhu W, Yang D, Zheng Z, Wang X, Lei Y. Double Filtration Plasmapheresis for Refractory Hypercholesterolemia in Drug‐Induced Cholestasis: A Case Report. Journal of Clinical Apheresis. 2026;41(2). doi:10.1002/jca.70117
BibTeX
@article{Liang2026,
author = {Liang, Yuling and Zhu, Wenjian and Yang, Dandan and Zheng, Zhihua and Wang, Xiaohua and Lei, Yan},
title = {Double Filtration Plasmapheresis for Refractory Hypercholesterolemia in Drug‐Induced Cholestasis: A Case Report},
journal = {Journal of Clinical Apheresis},
year = {2026},
volume = {41},
number = {2},
doi = {10.1002/jca.70117}
}
EUVIMED